Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy |
| |
Authors: | Mhashilkar A M Schrock R D Hindi M Liao J Sieger K Kourouma F Zou-Yang X H Onishi E Takh O Vedvick T S Fanger G Stewart L Watson G J Snary D Fisher P B Saeki T Roth J A Ramesh R Chada S |
| |
Affiliation: | Introgen Therapeutics Inc, Houston, TX 77030, USA. |
| |
Abstract: | BACKGROUND: The mda-7 gene (melanoma differentiation associated gene-7) is a novel tumor suppressor gene. The anti-proliferative activity of MDA-7 has been previously reported. In this report, we analyze the anti-tumor efficacy of Ad-mda7 in a broad spectrum of cancer lines. MATERIALS AND METHODS: Ad-mda7-transduced cancer or normal cell lines were assayed for cell proliferation (tritiated thymidine incorporation assay, Alamar blue assay, and trypan-blue exclusion assay), apoptosis (TUNEL, and Annexin V staining visualized by fluorescent microscopy or FACs analysis), and cell cycle regulation (Propidium Iodide staining and FACs analysis). RESULTS: Ad-mda7 treatment of tumor cells resulted in growth inhibition and apoptosis in a temporal and dose-dependent manner. The anti-tumor effects were independent of the genomic status of p53, RB, p16, ras, bax, and caspase 3 in these cells. In addition, normal cell lines did not show inhibition of proliferation or apoptotic response to Ad-mda7. Moreover, Ad-mda7-transduced cancer cells secreted a soluble form of MDA-7 protein. Thus, Ad-mda7 may represent a novel gene-therapeutic agent for the treatment of a variety of cancers. CONCLUSIONS: The potent and selective killing activity of Ad-mda7 in cancer cells but not in normal cells makes this vector a potential candidate for cancer gene therapy. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|